| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |